Company VIA Pharmaceuticals, Inc. Other OTC
Equities
VIAP
US92554T1034
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Small-molecule Drugs
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 04-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 04-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,000 | 0 | 0 | 100.00 % |
Stock B | 1 | 20,558,446 | 20,558,446 ( 100.00 %) | 0 |
Company contact information
VIA Pharmaceuticals, Inc.
750 Battery Street Suite 330
94111-9991, San Francisco
+
Sector
1st Jan change | Capi. | |
---|---|---|
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |